
MIG Update – October 12, 2026
Unreasonable Delay in Releasing IE Reports Triggers Special Award & Costs
In this week’s edition, the Tribunal addressed whether an insurer’s two-month delay in releasing an IE report recommending MIG removal which resulted in the Applicant preparing and filing initial hearing submissions constituted an unreasonable withholding or delay of benefits under section 10 of Regulation 664.
Virtual Training – Upcoming Sessions

Secure your seat for inHEALTH’s 2026 upcoming Virtual Training sessions!
- SABS Expedited – To Be Announced
*Eligible Participants receive 9 Substantive – CPD hours upon course completion
Course details & register here +
Factor – Special Award and Costs
In Mohamed Rizan v. TD General Insurance Company (25-005930) Imsamam Mohamed Rizan sought MIG removal and payment for three treatment plans. One day after he filed his initial written hearing submissions, TD removed him from the MIG. Days later, TD approved all three plans and withdrew a preliminary non-attendance issue, leaving only a s. 10 special award and costs in dispute.
The Applicant’s Position
Mohamed Rizan submitted that TD unreasonably withheld and delayed accident benefits by failing to promptly reschedule IEs and subsequently holding onto the resulting medical evidence. Specifically, although the multidisciplinary IE report issued on November 7, 2025, recommended removing him from the MIG, TD failed to release the report, revise its MIG position, or approve the pending treatment plans for two months, disclosing the report and removing him from the MIG only on January 8, 2026, one day after he had prepared and filed initial written hearing submissions. Relying on Amiri v. Allstate (23-012246), he argued the delay warranted an award of 50% for the denied psychological assessment and 35% for the chronic pain assessment and physiotherapy plans.
In addition he sought $1,000.00 in costs arguing that his legal costs were incurred entirely as a direct result of TD’s delay and lack of disclosure, which forced counsel to prepare and submit a full written hearing brief on issues that the insurer conceded immediately upon receipt of those submissions.
The Respondent’s Position
TD argued that any delay in adjusting the claim arose primarily from Mohamed Rizan repeated non-attendance at multiple scheduled IE’s between July 2023 and September 2023. Maintaining its denial based on the medical evidence available at the time, TD asserted that the historical timeline of the dispute was driven by Mohamed Rizan’s non-compliance rather than insurer inaction. Regarding the two-month gap between receiving the multidisciplinary IE report on November 7, 2025, and disclosing it on January 8, 2026, it characterized the delay as merely a “brief” administrative delay attributable to the holiday season.
On procedural grounds it submitted that arguments regarding MIG removal, plan approvals, and costs constituted new arguments, evidence, and caselaw that the Applicant ought to have included in initial hearing submissions. It submitted that requests for costs should have been brought in initial submissions rather than raised for the first time within reply submissions.
Get Your Stats Report!
inHEALTH’s Statistical Reports provide insights and analysis on the outcomes of Licence Appeal Tribunal (LAT) and court decisions.
Customize success rate reports on any variable relating to disputed AB claims captured in LAT and court decisions!
Decisions By Top 10 Insurers

*Sample Chart
Statistical Report fees are based on the complexity of your data request
Learn More & Get a Quote Here >
The Tribunal found:
-
- Mohamed Rizan was entitled to a special award of 15% of the values of the disputed treatment plans plus interest because TD held an November 7, 2025 IE report recommending MIG removal for two months, disclosing it and approving the treatment plans only the day after Mohamed Rizan filed written submissions. TD’s generic “holiday season” explanation was determined to be an unreasonable, excessive, and imprudent delay.
- Rather than granting the requested 35% to 50% award, the Tribunal capped it at 15%. It distinguished Amiri v. Allstate (23-012246) on the basis that Amiri involved longer delays, whereas the delay here was relatively short at just two months, and Mohamed Rizan provided no concrete evidence showing that those two months caused direct financial strain, medical harm, or specific hardship.
- TD’s unexplained failure to disclose the favorable IE report until after initial hearing submissions were filed forced Mohamed Rizan to incur unnecessary legal expense preparing a full written hearing brief on issues that TD conceded immediately thereafter, as such was entitled to the maximum cost award of $1000.
- TD’s motion to strike reply arguments regarding MIG removal, treatment plan approvals, and costs was denied. Under Rule 19.2, costs can be requested at any time prior to the release of a decision. Furthermore, because the late MIG removal and plan approvals occurred after initial submissions were filed, Mohamed Rizan could not have raised these factual developments or arguments any earlier.
- Mohamed Rizan was entitled to a special award of 15% of the values of the disputed treatment plans plus interest because TD held an November 7, 2025 IE report recommending MIG removal for two months, disclosing it and approving the treatment plans only the day after Mohamed Rizan filed written submissions. TD’s generic “holiday season” explanation was determined to be an unreasonable, excessive, and imprudent delay.
inHEALTH Keeps you LAT inFORMED With Access To:
1. LAT Compendium Database – a relational database of LAT and Divisional Court Decisions equipped with multiple search options, Smart Filters, and concise case summaries
2. Notifications: – weekly LAT inFORMER delivered to your inbox Wednesdays; Newly Added Decisions on Fridays and Breaking News as and when it happens
3. Research Support: – inHEALTH’s Live Chat Experts for guided searches and technical inquiries.
Sign up for a 14 day free trial below to experience the service and see how it can help guide your decision making.